CLINICAL_TRIALS
research
· 2025-03-21
Clinical Trial Update: NSAA NON-Interventional Study Protocol
Summary
This document provides an update on a non-interventional study protocol using NSAA for Duchenne muscular dystrophy and notes that the study is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Red Nucleus Enterprise Solutions, LLC | Conditions: Duchenne Muscular Dystrophy | Status: COMPLETED